• About us
• Contact

Advertisement

Organisation › Details

Biolojic Design Ltd.

Biolojic Design is committed to curing patients by designing and developing a pipeline of revolutionary therapeutics. Powered by AI, Biolojic's technology designs single and multi-specific antibodies precisely targeting predefined epitopes to execute novel biological programs. Focusing on diseases that involve the immune system, Biolojic develops a pipeline of antibodies that are designed to unlock the full potential of well-studied pathways. *

 

	Start	2021-03-08 existent
	Industry	AI-based drug discovery software
	Industry 2	therapeutic antibody
	Person	Ofran, Yanay (Biolojic Design 202103 CEO)
	Person 2	Pearlman, Micah (Biolojic Design 202103 COO before Teva Pharmaceuticals)
	Region	Tel Aviv
	Country	Israel
	City	n. a. Tel Aviv
		Address record changed: 2021-03-15
Basic data	Employees	n. a.
		* Document for »About Section«: Eli Lilly and Company. (3/8/21). "Press Release: Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes". Indianapolis, IN & Tel Aviv.
		Record changed: 2024-08-24

Advertisement

More documents for Biolojic Design Ltd.

• [1] Eli Lilly and Company. (3/8/21). "Press Release: Lilly and Biolojic Design Announce Research Collaboration to Discover and Develop Antibody Therapies for Diabetes". Indianapolis, IN & Tel Aviv....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2026. Made in Germany.